HCAT vs. YALA, GDYN, MOMO, FSLY, MGIC, BLND, DAVA, EVER, DSP, and DCBO
Should you be buying Health Catalyst stock or one of its competitors? The main competitors of Health Catalyst include Yalla Group (YALA), Grid Dynamics (GDYN), Hello Group (MOMO), Fastly (FSLY), Magic Software Enterprises (MGIC), Blend Labs (BLND), Endava (DAVA), EverQuote (EVER), Viant Technology (DSP), and Docebo (DCBO). These companies are all part of the "computer software" industry.
Health Catalyst vs. Its Competitors
Yalla Group (NYSE:YALA) and Health Catalyst (NASDAQ:HCAT) are both small-cap computer software companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk and earnings.
Yalla Group has higher revenue and earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than Yalla Group, indicating that it is currently the more affordable of the two stocks.
In the previous week, Health Catalyst had 3 more articles in the media than Yalla Group. MarketBeat recorded 3 mentions for Health Catalyst and 0 mentions for Yalla Group. Health Catalyst's average media sentiment score of 0.60 beat Yalla Group's score of 0.00 indicating that Health Catalyst is being referred to more favorably in the news media.
Health Catalyst has a consensus price target of $8.00, indicating a potential upside of 119.18%. Given Health Catalyst's stronger consensus rating and higher probable upside, analysts plainly believe Health Catalyst is more favorable than Yalla Group.
Yalla Group has a net margin of 40.94% compared to Health Catalyst's net margin of -23.34%. Yalla Group's return on equity of 20.67% beat Health Catalyst's return on equity.
Yalla Group has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500. Comparatively, Health Catalyst has a beta of 1.51, meaning that its stock price is 51% more volatile than the S&P 500.
4.7% of Yalla Group shares are held by institutional investors. Comparatively, 85.0% of Health Catalyst shares are held by institutional investors. 52.2% of Yalla Group shares are held by company insiders. Comparatively, 2.6% of Health Catalyst shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
Yalla Group beats Health Catalyst on 9 of the 16 factors compared between the two stocks.
Get Health Catalyst News Delivered to You Automatically
Sign up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding HCAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Health Catalyst Competitors List
Related Companies and Tools
This page (NASDAQ:HCAT) was last updated on 7/21/2025 by MarketBeat.com Staff
Free HCAT Stock Alerts